Fourth Annual Scientific Session of World’s Most Prominent Heart Valve Disease Societies Calls for Abstracts/Cases
New York (January 3, 2012) — The Fourth Annual Joint Scientific Session of the Heart Valve Society of America (HVSA) & Society for Heart Valve Disease (SHVD) is accepting abstract and case submissions for presentation. The meeting — Valves in the Heart of the Big Apple VII: Evaluation & Management of Valvular Heart Diseases 2012 — will take place from April 12 – 14, 2012 at the New York Marriott Marquis in New York City.
The conference — which focuses on diagnosis, evaluation and treatment of heart valve diseases — will include state-of-the-art lectures and specialized, medical, surgical and interventional sessions led by a faculty of over 100 of the world’s top heart valve disease clinicians and researchers.
The conference is inviting physicians and researchers from around the world to submit their most challenging valvular heart disease case for the consideration for presentation during the event.
Case categories include:
- Aortic regurgitation
- Mitral stenosis
- Mitral regurgitation
- Endocarditis
- Tricuspid valve disease
- Valve disease & AF
- Valve disease & aortic aneurysm
- Valve disease & CAD
In addition, the conference will provide the opportunity for authors to compete to present original research in oral or poster format.
Abstract categories include:
- Cell and molecular biology of valve and/or myocardial dysfunction in valve disease
- Objective evaluation of hemodynamic severity
- Epidemiology/Prognostication
- Surgical therapy — methods
- Surgical therapy — results
- Catheter-based therapy techniques and results
- Medical therapy
- Arrhythmias associated with valve diseases
- New valve prostheses
Cases and abstracts can be submitted through February 14, 2012. Abstracts chosen will appear in a special edition of Cardiology (Publication deadline: February 22, 2012)
Valvular heart diseases are among the most prominent causes of heart failure and premature cardiac death. It is estimated that more than 15 million Americans have some type of heart valve abnormality, and in more than five million, the disease is moderate to severe. Three to four million will require surgery at some time in their lives.
Valve diseases increase in frequency, as people grow older. With the aging of the Baby Boom generation, heart valve diseases are emerging as an important public health concern.
Valves in the Heart of the Big Apple VII: Evaluation and Management of Valvular Heart Diseases 2012 will provide state-of-the-art information for cardiologists, cardiothoracic surgeons, interventionalists, other physicians, researchers, allied health professionals, fellows and students from around the world.
Course directors are:
Maurice E. Sarano, MD, Mayo Clinic, Rochester, MN
Hartzell Schaff, MD, Mayo Clinic, Rochester, MN
Jeffrey S. Borer, MD, SUNY Downstate Medical Center, Brooklyn, NY, HVSA President
José-Luis Pomar, MD, Hospital Clinico de Barcelona, Barcelona, Spain, SHVD President
The conference is co-sponsored by the New York Cardiological Society of the New York State Chapter/American College of Cardiology.
Early registration fees are available through February 23, 2012.
The scientific session has been approved for AMA PRA Category 1 Credit. CME credits will be provided by SUNY Downstate Medical Center, Office of Continuing Medical Education.
The Heart Valve Society of America was founded to advance recognition and knowledge of the field by promoting research, educating medical professionals about the evaluation and treatment of heart valve disease, serving as an informational resource, and encouraging and facilitating education of future heart valve disease specialists.
The Society for Heart Valve Disease has as its objective to undertake, promote, support and encourage research and educate the public in the causes, prevention and treatment of heart valve disease.
# # #
Contact:
leslie j. yerman
info@heartvalvesocietyofamerica.org, 212-327-2107
Tags:
